UBIGENE

Application

application-banner
Application
  • All (305)
  • Case Study (65)
  • Expert Insights - Cell Culture (25)
  • Expert Insights - Cell Application (52)
  • Expert Insights - CRISPR Library (60)
  • Gene Editing Practical Tips (38)
  • Others (65)

In Vivo CRISPR Screening Identifies MED4 as a Regulator of Breast Cancer Metastatic Dormancy

Learn how in vivo CRISPR screening identified MED4 as a key regulator of breast cancer metastatic dormancy and recurrence.

type image

Immunity Study | Flavin Adenine Dinucleotide (FAD) Acts as a Dual Endogenous Inhibitor of cGAS and RIG-I Nucleic Acid Sensing

Published in Immunity: Learn how FLAD1-FAD regulates cGAS/RIG-I nucleic acid sensing. Powered by Ubigene's FLAD1 knockout A549 cell line model for innate immunity research.

type image

Gene Knockout in RAW 264.7 Cells: Key Model for Immune & Inflammation Studies

Discover how CRISPR/Cas9 gene knockout in RAW 264.7 cells advances research in inflammation, ferroptosis, and host-pathogen signaling. Explore KO models today.

type image

IF=23.2 | Ubigene Luc Cells Support Research on Oat β-Glucan in Colorectal Cancer

Discover how oat β-glucan enhances anti-PD-1 efficacy in colorectal cancer by enriching F. prausnitzii and key metabolites like butyrate and IPA in this latest study.

type image

HepG2 Gene-Edited Cell Lines: Applications in Metabolic and Genetic Disease Research

Discover how HepG2 cell lines advance liver research, metabolic disease modeling, and drug screening, with insights on CRISPR/Cas9 editing and LDLR/ATP7B targets.

type image
icon
to-top
Logo
E-mail: info@ubigene.com
WhatsAPP: +86 153 6067 3248
TEL: +86 153 6067 3248(Int'l)
Chat with an Expert
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Copyright © 2025 Ubigene. All rights reserved.
Privacy PolicyImpressum